JP2023541828A - 糖尿病を予測および／またはモニターするためならびにその処置のための方法および組成物 - Google Patents

糖尿病を予測および／またはモニターするためならびにその処置のための方法および組成物 Download PDF

Info

Publication number
JP2023541828A
JP2023541828A JP2023515292A JP2023515292A JP2023541828A JP 2023541828 A JP2023541828 A JP 2023541828A JP 2023515292 A JP2023515292 A JP 2023515292A JP 2023515292 A JP2023515292 A JP 2023515292A JP 2023541828 A JP2023541828 A JP 2023541828A
Authority
JP
Japan
Prior art keywords
snp
nucleic acid
cpg
methylation
appendix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023515292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023541828A5 (https=
Inventor
ミーシャンティニ ブイ． ドガン
ロバート フィリバート
ティムル ケイ． ドガン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Publication of JP2023541828A publication Critical patent/JP2023541828A/ja
Publication of JP2023541828A5 publication Critical patent/JP2023541828A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2023515292A 2020-09-04 2021-09-03 糖尿病を予測および／またはモニターするためならびにその処置のための方法および組成物 Pending JP2023541828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074836P 2020-09-04 2020-09-04
US63/074,836 2020-09-04
PCT/US2021/049078 WO2022051630A1 (en) 2020-09-04 2021-09-03 Methods and compositions for predicting and/or monitoring diabetes and treatments therefor

Publications (2)

Publication Number Publication Date
JP2023541828A true JP2023541828A (ja) 2023-10-04
JP2023541828A5 JP2023541828A5 (https=) 2024-09-09

Family

ID=80491519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515292A Pending JP2023541828A (ja) 2020-09-04 2021-09-03 糖尿病を予測および／またはモニターするためならびにその処置のための方法および組成物

Country Status (7)

Country Link
US (1) US20230313302A1 (https=)
EP (1) EP4208571A4 (https=)
JP (1) JP2023541828A (https=)
CN (1) CN116490622A (https=)
AU (1) AU2021338376A1 (https=)
CA (1) CA3194027A1 (https=)
WO (1) WO2022051630A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250130967A1 (en) * 2023-10-20 2025-04-24 Stratus Technologies Ireland Ltd. Systems and methods to preconfigure a hardware module

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019520066A (ja) * 2016-06-08 2019-07-18 ユニバーシティー オブ アイオワ リサーチ ファンデーション 心血管疾患の素因を検出するための組成物および方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805918D0 (en) * 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
EP1268856A2 (de) * 2000-04-07 2003-01-02 Epigenomics AG Detektion von snp's und cytosin-methylierungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019520066A (ja) * 2016-06-08 2019-07-18 ユニバーシティー オブ アイオワ リサーチ ファンデーション 心血管疾患の素因を検出するための組成物および方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUSAMETTIN GUL ET AL.: "Discoveringmissing heritability and early riskprediction for type 2 diabetes: a newperspective forge", TURKISH JOURNAL OF MEDICAL SCIENCES, vol. 44, no. 6, JPN6025034001, 2014, pages 946 - 954, ISSN: 0005665987 *
JIANTAO MA ET AL.: "WholeBlood DNA Methylation Signatures of Diet AreAssociated With CardiovascularDisease Risk Factorsa", CIRCULATION: GENOMICANDPRECISIONMEDICINE, vol. 13, no. 4, JPN6025034000, August 2020 (2020-08-01), pages 324 - 333, ISSN: 0005665988 *
ROBY JOEHANES ET AL.: "EpigeneticSignatures of Cigarette Smoking", CIRC CARDIOVASCGENET, vol. 9, no. 5, JPN6025033999, 2016, pages 436 - 447, ISSN: 0005665989 *

Also Published As

Publication number Publication date
CA3194027A1 (en) 2022-03-10
EP4208571A4 (en) 2024-10-23
US20230313302A1 (en) 2023-10-05
EP4208571A1 (en) 2023-07-12
WO2022051630A1 (en) 2022-03-10
AU2021338376A1 (en) 2023-04-13
CN116490622A (zh) 2023-07-25

Similar Documents

Publication Publication Date Title
US12043869B2 (en) Compositions and methods for detecting predisposition to cardiovascular disease
US20260035749A1 (en) Methods and compositions for predicting and/or monitoring cardiovascular disease and treatments therefor
JP2023541828A (ja) 糖尿病を予測および／またはモニターするためならびにその処置のための方法および組成物
US20150292016A1 (en) Novel markers for mental disorders
WO2024206958A2 (en) Methods and compositions for predicting and/or monitoring cardiovascular disease and interventions therefor
Busse et al. High‐Resolution genomic arrays identify CNVs that phenocopy the chromosome 22q11. 2 deletion syndrome
US20100003691A1 (en) Genetic Markers Associated with Degenerative Disc Disease and Uses Thereof
US20220235418A1 (en) Use of Biomarkers for Degenerative Disc Disease
JP2007510404A (ja) アルツハイマー病の発症年齢に関連するｎｔｒｋ１遺伝子マーカー
WO2014121180A1 (en) Genetic variants in interstitial lung disease subjects
CN105765077B (zh) 测定抗甲状腺药物诱导的粒细胞缺乏症风险的检测方法以及测定用试剂盒
HK40061532A (en) Compositions for detecting predisposition to cardiovascular disease
HK40000428B (en) Compositions for detecting predisposition to cardiovascular disease

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240830

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240830

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250815

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250819

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260115